LADENBURG THALMANN FINANCIAL SERVICES INC. - IMMUNE PHARMACEUTICALS INC ownership

IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 18 filers reported holding IMMUNE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$0
-100.0%
1,000
-96.4%
0.00%
Q4 2016$5,00027,500
+1275.0%
0.00%
Q3 2016$02,000
+100.0%
0.00%
Q2 2016$01,0000.0%0.00%
Q1 2016$0
-100.0%
1,0000.0%0.00%
Q4 2015$1,0000.0%1,0000.0%0.00%
Q3 2015$1,000
-50.0%
1,0000.0%0.00%
Q2 2015$2,0000.0%1,0000.0%0.00%
Q1 2015$2,0001,0000.00%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Geduld E E 35,000$63,0000.04%
Ifrah Financial Services, Inc. 21,956$39,0000.02%
Bank Pictet & Cie (Europe) AG 12,900$23,0000.01%
Pine River Capital Management L.P. 250,000$260,0000.00%
Virtu KCG Holdings LLC 55,599$100,0000.00%
A.R.T. Advisors, LLC 10,408$18,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 1,000$2,0000.00%
CITIGROUP INC 255$00.00%
GOLDMAN SACHS GROUP INC 33,616$60,0000.00%
MORGAN STANLEY 40$00.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders